Kidney Failure, Acute
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
826
|
32
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2019 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.040 |
None |
0.750 |
4 |
|
1994 |
2009 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
4 |
5
|
2016 |
2019 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2017 |
Pyelonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
71
|
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2019 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.030 |
None |
1.000 |
3 |
|
2019 |
2019 |
Maturation defect
|
phenotype |
|
Acquired Abnormality
|
43
|
2
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2013 |
Neuralgia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
767
|
16
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Creatinine measurement, serum (procedure)
|
phenotype |
|
Laboratory Procedure
|
124
|
243
|
0.100 |
None |
1.000 |
2 |
3
|
2016 |
2018 |
Urolithiasis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
72
|
33
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1499
|
201
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
2 |
2
|
2018 |
2019 |
Hydrocephalus, Normal Pressure
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
44
|
6
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2002 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3
|
disease |
|
Disease or Syndrome
|
2
|
1
|
0.200 |
None |
1.000 |
2 |
|
2005 |
2014 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2012 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2012 |
Nephronophthisis 1
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
18
|
6
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2016 |
Fabry Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
108
|
206
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2014 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Hyperuricemic Nephropathy, Familial Juvenile 2
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
1
|
0.200 |
None |
1.000 |
2 |
|
2005 |
2014 |
Congestive heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1760
|
165
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Alcohol Use Disorder
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
218
|
54
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
Idiopathic hypercalciuria
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
20
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |